BRIEF published on 04/09/2025 at 18:39, 1 year ago PolyPeptide Group's AGM 2025 Approvals Financial Statements Board Re-election Capital Band Shareholder Approvals AGM 2025
BRIEF published on 04/09/2025 at 18:39, 1 year ago Approbations de l'AGA 2025 du groupe PolyPeptide États Financiers Réélection Du Conseil D'administration Approbations Des Actionnaires Assemblée Générale Annuelle 2025 Bande Majuscule
PRESS RELEASE published on 04/09/2025 at 18:34, 1 year ago PolyPeptide announces results of the annual General Meeting 2025 PolyPeptide Group AG announces successful outcome of the annual General Meeting 2025 with shareholders approving all proposals presented by the Board of Directors Board Of Directors Shareholders Approval PolyPeptide Group AGM 2025
BRIEF published on 03/18/2025 at 07:05, 1 year 1 month ago PolyPeptide Group Announces Annual General Meeting 2025 Annual General Meeting Board Elections PolyPeptide Group Shareholder Proposals Capital Strategy
BRIEF published on 03/18/2025 at 07:05, 1 year 1 month ago Le groupe PolyPeptide annonce son assemblée générale annuelle 2025 Assemblée Générale Annuelle Élections Du Conseil D'administration Stratégie De Capital Groupe De PolyPeptides Propositions Des Actionnaires
PRESS RELEASE published on 03/18/2025 at 07:00, 1 year 1 month ago PolyPeptide publishes invitation to the annual General Meeting 2025 PolyPeptide Group AG invites shareholders to its fourth annual General Meeting on 9 April 2025 in Zug. Proposals include re-election of Board members, introduction of capital band, and approval of financial reports Board Of Directors Financial Reports General Meeting PolyPeptide Group Capital Band
BRIEF published on 03/11/2025 at 07:00, 1 year 1 month ago PolyPeptide annonce une forte rentabilité et une forte croissance dans le cadre de son expansion stratégique Rentabilité Croissance Des Revenus Des Flux De Trésorerie Extension De Capacité Prévisions Pour 2025
BRIEF published on 03/11/2025 at 07:00, 1 year 1 month ago PolyPeptide Reports Strong Profitability and Growth Amid Strategic Expansion Revenue Growth Cash Flow Profitability Capacity Expansion 2025 Forecast
PRESS RELEASE published on 03/11/2025 at 06:55, 1 year 1 month ago PolyPeptide with substantial improvements in profitability and cash flow, positioned for strong growth PolyPeptide Group AG reports EUR 336.8 million revenue for 2024, EBITDA of EUR 25.4 million, and strong cash flow. Guidance includes accelerated growth of 10%-20% in 2025 EBITDA Revenue Cash Flow PolyPeptide Group AG 2025 Guidance
BRIEF published on 01/08/2025 at 07:05, 1 year 3 months ago PolyPeptide Group agrandit son site de production à Malmö Investissement Croissance Des Revenus Création D'emplois Extension De La Production Site De Malmö
Published on 05/06/2026 at 02:17, 3 hours 36 minutes ago Troubadour Announces Share Consolidation and Effective Date
Published on 05/06/2026 at 02:00, 3 hours 53 minutes ago Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
Published on 05/06/2026 at 02:00, 3 hours 53 minutes ago Alset AI Announces Shares for Debt Transaction
Published on 05/06/2026 at 01:30, 4 hours 23 minutes ago Presentation to RIU Sydney Resources Roundup
Published on 05/06/2026 at 01:20, 4 hours 33 minutes ago Empress Grants Stock Options and Equity Incentives
Published on 05/06/2026 at 03:05, 2 hours 47 minutes ago ARC Group Advises Magnax on €35.5 Million Strategic Investment from Pan-International Industrial Corp. and Foxconn Group
Published on 05/06/2026 at 03:05, 2 hours 47 minutes ago Bank of America Convenes Global Leaders in Asia Pacific for its Breakthrough Technology Dialogue
Published on 05/06/2026 at 01:35, 4 hours 17 minutes ago VERNAL CAPITAL ACQUISITION CORP. ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING
Published on 05/06/2026 at 00:05, 5 hours 47 minutes ago ESOC 2026: Rising stroke rates highlight widening ethnic and socioeconomic inequalities across populations, major study finds
Published on 05/05/2026 at 23:05, 6 hours 47 minutes ago Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
Published on 05/05/2026 at 19:00, 10 hours 53 minutes ago Combined General Meeting of Air Liquide Shareholders of May 5, 2026
Published on 05/05/2026 at 19:00, 10 hours 53 minutes ago Assemblée Générale Mixte des Actionnaires d’Air Liquide du 5 mai 2026
Published on 05/05/2026 at 18:40, 11 hours 13 minutes ago Mise en œuvre du programme de rachat d’actions
Published on 05/05/2026 at 18:03, 11 hours 49 minutes ago Aéroports de Paris SA - Actions et droits de vote au 30 avril 2026
